Complicating cure: How Australian criminal law shapes imagined post‐hepatitis C futures
暂无分享,去创建一个
S. Fraser | K. Seear | S. Mulcahy | A. Farrugia | Kylie Valentine | E. Lenton | Dion Kagan | Kate Seear
[1] K. Seear,et al. Echoes and Antibodies: Legal Veridiction and the Emergence of the Perpetual Hepatitis C Subject , 2022, Social & Legal Studies.
[2] G. Dore. Elimination of hepatitis C in Australia by 2030: a decade and counting , 2021, Australian prescriber.
[3] K. Seear,et al. Beyond a 'post-cure' world: Sketches for a new futurology of hepatitis C. , 2021, The International journal on drug policy.
[4] J. Pawlotsky,et al. EASL recommendations on treatment of hepatitis C - Final update of the series. , 2020, Journal of hepatology.
[5] M. Hellard,et al. Improving hepatitis C direct‐acting antiviral access and uptake: A role for patient‐reported outcomes and lived experience , 2018, Journal of viral hepatitis.
[6] M. Harris. Managing expense and expectation in a treatment revolution: Problematizing prioritisation through an exploration of hepatitis C treatment 'benefit'. , 2017, The International journal on drug policy.
[7] M. Hellard,et al. Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade. , 2017, The International journal on drug policy.
[8] K. R. Reddy,et al. Review article: safety and tolerability of direct‐acting anti‐viral agents in the new era of hepatitis C therapy , 2016, Alimentary pharmacology & therapeutics.
[9] C. Rice,et al. Hepatitis C: Treatment triumphs , 2014, Nature.
[10] Raymond T Chung,et al. Curing chronic hepatitis C--the arc of a medical triumph. , 2014, The New England journal of medicine.
[11] C. Treloar,et al. The Experience of Interferon-Based Treatments for Hepatitis C Infection , 2005, Qualitative health research.